Stiff N Sore

Arnica Montana, Bellis Perennis, Ruta Graveolens,rhus Toxicondendron


Suco Inc
Human Otc Drug
NDC 64363-0045
Stiff N Sore also known as Arnica Montana, Bellis Perennis, Ruta Graveolens,rhus Toxicondendron is a human otc drug labeled by 'Suco Inc'. National Drug Code (NDC) number for Stiff N Sore is 64363-0045. This drug is available in dosage form of Cream. The names of the active, medicinal ingredients in Stiff N Sore drug includes Arnica Montana - 4 [hp_X]/480g Bellis Perennis - 4 [hp_X]/480g Ruta Graveolens Whole - 4 [hp_X]/480g Toxicodendron Pubescens Whole - 4 [hp_X]/480g . The currest status of Stiff N Sore drug is Active.

Drug Information:

Drug NDC: 64363-0045
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Stiff N Sore
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Arnica Montana, Bellis Perennis, Ruta Graveolens,rhus Toxicondendron
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Suco Inc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Cream
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:ARNICA MONTANA - 4 [hp_X]/480g
BELLIS PERENNIS - 4 [hp_X]/480g
RUTA GRAVEOLENS WHOLE - 4 [hp_X]/480g
TOXICODENDRON PUBESCENS WHOLE - 4 [hp_X]/480g
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Feb, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 22 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date: 31 Dec, 2024
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Suco Inc
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0685683000020
0685683000013
UPC stands for Universal Product Code.
UNII:O80TY208ZW
2HU33I03UY
181JI0338P
C1S185Y74S
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
64363-0045-1120 g in 1 JAR (64363-0045-1)01 Feb, 2015N/ANo
64363-0045-2240 g in 1 JAR (64363-0045-2)02 Feb, 2015N/ANo
64363-0045-3480 g in 1 JAR (64363-0045-3)02 Feb, 2015N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

A topical for sore achy muscles and stiff joints

Product Elements:

Stiff n sore arnica montana, bellis perennis, ruta graveolens,rhus toxicondendron gel arnica montana arnica montana aloe bellis perennis bellis perennis toxicodendron pubescens whole toxicodendron pubescens whole ruta graveolens whole ruta graveolens whole stiff n sore arnica montana, bellis perennis, ruta graveolens,rhus toxicondendron arnica montana arnica montana shea butter bellis perennis bellis perennis toxicodendron pubescens whole toxicodendron pubescens whole ruta graveolens whole ruta graveolens whole

Indications and Usage:

Homeopathic preperation topical for sore achy muscles and stiff joints as a result of everexertion, injury, arthritis, etc.

Warnings:

Caution: keep this and all medications out of reach of children. for external use only, keep away from eyes, do not use on open skin.

Dosage and Administration:

Directions: apply liberly to affected area 2-3 times a day, rub in well. if necessary, use hot or cold applications to assist with comfort and healing. for external use only, keep away from eyes, do not use on open wounds.

Package Label Principal Display Panel:

Cream label gel label


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.